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Cerebral function is associated with exceptionally high metabolic activity, and requires
continuous supply of oxygen and nutrients from the blood stream. Since the
mid-twentieth century the idea that brain energy metabolism is coupled to neuronal
activity has emerged, and a number of studies supported this hypothesis. Moreover,
brain energy metabolism was demonstrated to be compartmentalized in neurons and
astrocytes, and astrocytic glycolysis was proposed to serve the energetic demands
of glutamatergic activity. Shedding light on the role of astrocytes in brain metabolism,
the earlier picture of astrocytes being restricted to a scaffold-associated function in
the brain is now out of date. With the development and optimization of non-invasive
techniques, such as nuclear magnetic resonance spectroscopy (MRS), several groups
have worked on assessing cerebral metabolism in vivo. In this context, 1H MRS
has allowed the measurements of energy metabolism-related compounds, whose
concentrations can vary under different brain activation states. 1H-[13C] MRS, i.e.,
indirect detection of signals from 13C-coupled 1H, together with infusion of 13C-enriched
glucose has provided insights into the coupling between neurotransmission and glucose
oxidation. Although these techniques tackle the coupling between neuronal activity and
metabolism, they lack chemical specificity and fail in providing information on neuronal
and glial metabolic pathways underlying those processes. Currently, the improvement of
detection modalities (i.e., direct detection of 13C isotopomers), the progress in building
adequate mathematical models along with the increase in magnetic field strength now
available render possible detailed compartmentalized metabolic flux characterization.
In particular, direct 13C MRS offers more detailed dataset acquisitions and provides
information on metabolic interactions between neurons and astrocytes, and their role
in supporting neurotransmission. Here, we review state-of-the-art MR methods to study
brain function and metabolism in vivo, and their contribution to the current understanding
of how astrocytic energy metabolism supports glutamatergic activity and cerebral
function. In this context, recent data suggests that astrocytic metabolism has been
underestimated. Namely, the rate of oxidative metabolism in astrocytes is about half
of that in neurons, and it can increase as much as the rate of neuronal metabolism in
response to sensory stimulation.
Keywords: brain energy metabolism, neurotransmitter metabolism, neuron-glia interaction, neuronal activity,
MRS, fMRI, mathematical modeling
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INTRODUCTION
Cerebral function requires the cooperative interaction between
different cell types, namely neurons, astrocytes, microglia and
oligodendrocytes, and depends on high metabolic activity
supported by continuous supply of oxygen and glucose from
the blood (Siesjö, 1978). Blood flow is indeed directly related
to the cerebral metabolic rate of glucose consumption (CMRglc)
(Sokoloff, 1978). Although the adult human brain represents
only 2% of the total body weight, it consumes up to 20% of
the total glucose metabolism under normal resting physiological
conditions (e.g., Rolfe and Brown, 1997). Since themid-twentieth
century the idea that brain energy metabolism is coupled to
neuronal activity has emerged (McIlwain et al., 1951; Van den
Berg et al., 1969), and a number of studies supported this
hypothesis (Pellerin and Magistretti, 1994; Poitry-Yamate et al.,
1995; Tsacopoulos et al., 1997). Notably, in the 90’s, brain energy
metabolism was demonstrated to be compartmentalized between
neurons and astrocytes, and astrocytic glycolysis was proposed
to serve the energetic demands of glutamatergic activity (Pellerin
and Magistretti, 1994; Poitry-Yamate et al., 1995; Tsacopoulos
et al., 1997).
Ogawa et al. reported in 1992 the changes in the apparent
transverse relaxation time T∗2 due to variations in local blood
oxygen consumption (CMRO2), cerebral blood flow (CBF) and
cerebral blood volume (CBV; Ogawa et al., 1992). This discovery
formed the basis of a powerful technique used nowadays to
study brain activity: blood oxygenation level-dependent (BOLD)
functional magnetic resonance imaging (fMRI). Under the
assumption of brain metabolism being segregated into two main
Abbreviations: 20-HETE, 20-hydroxyeicosatetraenoic acid; AA, arachidonic
acid; ADP, adenosine 5′-diphosphate; AMPA, α-amino-3-hydroxyl-5-methyl-
4-isoxazole-propionate; ANLS, astrocyte-neuron lactate shuttle; AST, aspartate
transaminase; ATP, adenosine 5′-triphosphate; BBB, blood-brain barrier; BOLD,
blood oxygenation level-dependent; cAMP, cyclic adenosinemonophosphate; CBF,
cerebral blood flow; CBV, cerebral blood volume; CMRglc, cerebral metabolic rate
of glucose; CMRO2, cerebral metabolic rate of oxygen; COX, cyclooxygenase;
DNP, dynamic nuclear polarization; EAAT, excitatory amino acid transporters;
EET, epoxeicosatrienoic acid; FADH2, flavin adenine dinucleotide (reduced
form); FE, fractional enrichment; fMRI, functional magnetic resonance imaging;
fMRS, functional magnetic resonance spectroscopy; FRET, fluorescence resonance
energy transfer; GDH, glutamate dehydrogenase; GDP, guanosine diphosphate;
GLS, glutaminase; GLUT, glucose carrier; GS, glutamine synthetase; GTP,
guanosine triphosphate; IP3, inositol 1,4,5-triphosphate; Kt, apparent Michaelis
constant of glucose transport; MCT, monocarboxylate transporters; ME, malic
enzyme; mGluR, metabotropic glutamate receptor; MR, magnetic resonance;
MRP, multidrug resistance proteins; MRS, magnetic resonance spectroscopy;
NADH, nicotinamide adenine dinucleotide (reduced form); NMDA, N-methyl-
D-aspartate; NO, nitric oxide; NOS, nitric oxide synthase; Nrf2, nuclear
factor-erythroid 2-realted factor-2; OAA, oxaloacetate; OG, 2-oxoglutarate; P2Y,
purinergic receptors; PC, pyruvate carboxylase; PDH, pyruvate dehydrogenase
complex; PEPCK, phosphoenolpyruvate carboxykinase; PET, positron emission
tomography; PFK, phosphofructokinase-1; PFKFB3, fructose-2,6-bisphosphatase-
3; PGE2, prostaglandins E2; PK, pyruvate kinase; PLA2, phospholipase A2; PLC,
phospholipase C; SA, system A transporter; sGC, soluble guanylate cyclase;
SLC2, solute carrier family 2; SN, system N transporter; SNARE, soluble N-
ethylmaleimide-sensitive factor activating protein receptor; CA, tricarboxylic acid
cycle; Tmax: apparent maximum transport rate of glucose transport; VGLUT,
vesicular glutamate transporter; VSOAC, volume-sensitive organic osmolyte-
anion channel.
compartments, neurons and astrocytes (which is valid for cortical
gray matter), and based on measurements of the glutamate-
glutamine cycle and glucose oxidation rates, a quantitative
interpretation of functional imaging by integrating oxidative
neuroenergetics of neuronal processes was thereafter suggested
(Shulman and Rothman, 1998). In this context, the main
metabolic costs underlying neuronal activity involved not only
the maintenance of the glutamate-glutamine cycle, but also
the generation and propagation of action potentials, uptake
and recycling of neurotransmitters from the synaptic cleft, and
restoration and maintenance of resting membrane potential
(reviewed in Attwell and Laughlin, 2001). However, besides the
proposed coupling between neurotransmission and neuronal
oxidative metabolism, data acquired during the past decades in
other experimental conditions and models suggested substantial
astrocytic contribution to metabolism (Gruetter et al., 2001 and
reviewed in Lanz et al., 2013) and blood flow regulation (reviewed
in Attwell et al., 2010). A recent analysis on K+-dependent
stimulation of astrocytic metabolism suggests that the actual
glial contribution to total energy metabolism has been long
underestimated (DiNuzzo et al., 2017).
This article reviews the biochemical mechanisms associated
with energy metabolism in brain cells, and provides a critical
review of the traditional view of astrocytes being glycolytic
and neurons oxidative, which has been challenged over the
past years by evidence pointing to important rates of oxidative
respiration in astrocytes, namely during increased brain activity.
13C MRS along with infusion of 13C-labeled substrates and the
use of compartment models as tools to probe glial and neuronal
metabolism will then be described. Data recently acquired in our
laboratory (Sonnay et al., 2016, 2017) assessing the matter of glial
and neuronal oxidative metabolism coupled to neuronal activity
is then presented and potential usage of the mitochondrial ATP
production in astrocytes is further discussed.
BRAIN GLUCOSE UPTAKE AND
METABOLISM
The brain can consume several substrates, such as lactate
(Bouzier et al., 2000; Wyss et al., 2011), acetate (Cerdan et al.,
1990), fatty acids (Kuge et al., 1995) and ketone bodies (Künnecke
et al., 1993), but energy metabolism in the adult brain primarily
relies on glucose provided from the blood to fuel activity both in
the resting and activated states (reviewed in Sokoloff, 2004).
Uptake of monocarboxylates, such as lactate, pyruvate, and
ketone bodies, is mediated by monocarboxylate transporters
(MCT) along with the co-transport of one 1H for each molecule.
The isoform MCT1 is expressed in the endothelial cells and
in astrocytes (reviewed in Pierre and Pellerin, 2005), MCT4 in
astrocytes and MCT2 in neurons (Bergersen et al., 2002; and
reviewed in Barros and Deitmer, 2010).
In mammalian brain cells, glucose transport and utilization is
predominantly mediated by facilitated diffusion through glucose
transporters GLUT1 and GLUT3 that belong to the Solute
Carrier Family 2 (SLC2). GLUT1 is present in all brain cells,
with high density in astrocytes and endothelial cells of the
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capillaries, but less in neurons (reviewed in Maher et al., 1994).
In contrast, GLUT3 expression is almost restricted to neurons
(Maher et al., 1992, 1996). GLUT1 is thus the main carrier
involved in the import of glucose into the brain from the blood,
and its apparent affinity for glucose transport is lower than that of
GLUT3 (discussed in Simpson et al., 2007). These two facilitative
carriers mediate energy-independent transport of glucose bi-
directionally along a concentration gradient, which is maintained
by continuous phosphorylation of intracellular glucose by the
glycolytic enzyme hexokinase, and exist in sufficient density to
ensure that glucose transport is not rate-limiting for CMRglc
(Gruetter et al., 1998b; Barros et al., 2007; Duarte et al., 2009).
GLUT4 in neurons (Ashrafi et al., 2017) and GLUT2 in both
neurons and astrocytes (Thorens, 2015) have also been shown
to transport glucose. However, GLUT2 and GLUT4 are carriers
involved in specific functions in certain brain areas, and are
likely to have a minor role on glucose uptake for cellular
fueling.
After entering the cells, glucose is converted via glycolysis to
two molecules of pyruvate with net formation of 2 ATP and 2
NADH in the cytosol. Pyruvate can then be reduced to lactate
mediating NAD+ formation, transaminated to alanine or enter
mitochondria via the mitochondrial pyruvate carrier, where it
is decarboxylated to acetyl-CoA by the pyruvate dehydrogenase
complex (PDH) with formation of CO2 and NADH (Patel and
Korotchkina, 2001). Acetyl-CoA condensates with oxaloacetate
entering therefore oxidative metabolism via the tricarboxylic
(TCA) cycle. Each turn of the TCA cycle yields 3 NADH,
1 FADH2 and 1 GTP molecules. The electron-transfer chain
generates a gradient of H+ across the mitochondrial membrane,
which is used by the ATP synthase for ATP production. As
each NADH and FADH2 molecules generates 2.5 and 1.5 ATP
respectively, complete oxidation of one molecule of glucose
produces 30 or 32 ATP, depending on the transport of cytosolic
NADH to mitochondria either in the malate-aspartate or in the
glycerol 3-phosphate mitochondrial shuttles (Voet and Voet,
1995).
Oxidation of glucose-derived pyruvate through the TCA
cycle not only provides the bulk of energy produced to support
cerebral function (reviewed in Hertz and Dienel, 2002), but
also involves the generation of de novo amino acids, namely
glutamate (reviewed in Gruetter, 2002). Neurons extensively
release glutamate and need therefore a replenishment system
to ensure adequate neurotransmitter levels. Namely, synthesis
of de novo oxaloacetate from pyruvate is catalyzed by the
glial-specific enzyme pyruvate carboxylase (PC; Gamberino
et al., 1997), mediating CO2 fixation in an energy-dependent
manner, increasing therefore the number of carbon skeletons
in the TCA cycle. Oxaloacetate formed through pyruvate
carboxylation condensates with acetyl-CoA to produce new
glutamate molecules (Waagepetersen et al., 2001). In addition,
under low acetyl-CoA concentration, pyruvate can be produced
cataplerotically from TCA cycle intermediates (pyruvate
recycling): from oxaloacetate, mediated by the combined action
of phosphoenolpyruvate carboxykinase (PEPCK) and pyruvate
kinase (PK; Cruz et al., 1998), occurring in astrocytes (Sonnewald
et al., 1996) and to less extent in neurons (Cruz et al., 1998), and
from malate by the malic enzyme (ME; Bakken et al., 1997; Cruz
et al., 1998; Sonnewald, 2014).
Once glutamate is taken by astrocytes, it can be converted to
glutamine in an energy-dependent manner via the glial-specific
enzyme, glutamine synthetase (GS; Derouiche and Frotscher,
1991). Glutamine is then transported to neurons via the System
N transporter (SN1) in astrocytes (Chaudhry et al., 1999) and
the System A transporters (SA1 and SA2) in neurons (Chaudhry
et al., 2002), and converted to glutamate by glutaminase (GLS),
completing therefore the glutamate-glutamine cycle (Shen et al.,
1999; Zwingmann and Leibfritz, 2003), which is now accepted
as a major mechanism for maintaining synaptic transmission.
Therefore, while about 90% of the brain’s glutamate resides in
neurons (estimated between 5 and 16% in glia of the rodent
brain; Tiwari et al., 2013; Lanz et al., 2014), most of the glutamine
has been localized to astrocytes (Ottersen et al., 1992; Cruz and
Cerdan, 1999). Glutamate can also re-enter the TCA cycle (Qu
et al., 2001; Hertz et al., 2007; Sonnewald, 2014) notably by the
reversible aspartate transaminase (AST) or the glial-abundant
reversible enzyme glutamate dehydrogenase (GDH; Karaca
et al., 2015), being oxidized for further energy or amino acid
production. Consequently, the glutamate-glutamine cycle is not
a stoichiometric process, as a number of amino acid molecules
can be used in other metabolic pathways depending on cellular
requirements (McKenna, 2007). Glutamine can diffuse out of
the brain parenchyma and be used for ammonia detoxification
(Zwingmann and Leibfritz, 2003). In addition, glutamate can
have other fates than being converted to glutamine, such as
formation of GABA and glutathione, and be synthetized from
other substrates than glucose, namely lactate or ketone bodies.
Amino acids can also be used for biosynthetic pathways and
derived from protein degradation (McKenna, 2007; Figure 1).
GLIAL SUPPORT TO CEREBRAL
FUNCTION
Scaffold-Associated Role of Astrocytes
The term astrocyte originates etymologically from the Greek
words astron (star) and cyte (cell). They belong to the general
group of macroglia cells (Kettenmann and Verkhratsky, 2008),
where glia is derived from the Greek word gliok (glue). Astrocytes
were initially described in themiddle of the nineteenth century by
Rudolf Virchow (Virchow, 1856), who named nervenkitt (nerve-
putty) the “gelatinous” substance in the brain, and later by
Camillo Golgi, who hypothesized a role of astrocytes in nutrient
distribution to the brain parenchyma (Golgi, 1886).
Several cytological studies on rats (Kacem et al., 1998;
Mathiisen et al., 2010) and mice (Halassa et al., 2007) have shown
that astrocytes are anatomically polarized cells that associate both
with neurons and the vasculature: whereas perisynaptic processes
contact neurons, vascular processes (or endfeet) surround
intraparenchymal blood vessels (i.e., blood-brain barrier, BBB;
Kacem et al., 1998). Perisynaptic processes largely express
glutamate transporters (EAAT1 and EAAT2), while endfeet are
more specialized in nutrient uptake and express large amounts
of glucose transporters (GLUT1; Iadecola and Nedergaard,
2007). Therefore, the etymology reflects what astrocytes have
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FIGURE 1 | Schematic representation of possible pathways mediating neurometabolic coupling. Upon action potential glutamate is released in the synaptic
cleft and activates the post-synaptic glutamate receptors (mGluR, NMDA, AMPA, and kainate). Glutamate molecules that are left in the synaptic cleft are transported
into astrocytes via the glutamate transporters (EAAT) using the electrochemical gradient of Na+ (1 glutamate is transported with 3 Na+) and antiport of one K+. The
Na+ gradient is reestablished by the Na+/K+-ATPase, an energy-dependent process (3 Na+ anti-transported with 2 K+). Glial glutamate is then converted to
glutamine by glutamine synthetase (GS), an energy-dependent reaction, and is shuttled back to neurons via system N transporter (SN1) and system A transporter
(SA1,2). In neuron, glutamine is hydrolyzed by glutaminase (GLS) into glutamate that is packed into vesicles by VGLUT for further glutamate release. Glutamate uptake
into astrocytes is associated with glucose transport from plasma via GLUT1, and both glycolysis and oxidative metabolism via pyruvate dehydrogenase (PDH) take
place. Glucose is also transported into neurons via GLUT3, where it also undergoes non-oxidative and oxidative metabolism. Produced-glutamate can re-enter the
TCA cycle (i.e., glutamate oxidation) via glutamate dehydrogenase (GDH) or aspartate transaminase (AST). In astrocytes, pyruvate can be produced cataplerotically
either from oxaloacetate, mediating the combined action of phosphoenolpyruvate carboxykinase (PEPCK) and pyruvate kinase (PK), or from malate by the malic
enzyme (ME; i.e., pyruvate recycling). Glycolytic-derived pyruvate is converted to lactate by lactate dehydrogenase (LDH) and exchanged between neurons and
astrocytes through monocarboxylate transporters (MCT1,4 and MCT2). Lactate can be converted back to pyruvate via LDH and therefore regulate the NADH/NAD+
redox ratio. In astrocytes, pyruvate carboxylase (PC) produces oxaloacetate from pyruvate in mediating CO2 fixation in an energy-dependent manner. Oxaloacetate
condensates then with acetyl-CoA to produce de novo molecules of glutamate. The left and right cells represent an astrocyte and a neuron, respectively. The
difference in TCA cycle size reflects the fact that neurons are more oxidative than astrocytes. The red circle is a blood vessel, the surrounding darker layer represents
the endothelial cells and the thicker outer line is the smooth muscle cells (or pericytes). Word in bold red and bold purple corresponds to energy-producing and
consuming processes, respectively. Enzymes are in gray italic. *Either one or the other enzyme acts.
traditionally been considered, satellite housekeeping cells of
the brain, whose sole purpose is to serve neuronal cells in
creating a favorable environment for the neurons to function
efficiently. In this conventional view, astrocytes control pH and
local ion homeostasis, deliver nutrients and clean neuronal waste
(Nedergaard et al., 2003).
Compartmentalization of Brain Energy
Metabolism
However, the role of astrocytes extends beyond physically
supporting neurons. Interconnected via gap junctions, astrocytes
form a complex functional network that detects and modulates
neuronal activity, integrates and transmits surrounding signals,
controls brain vasculature for nutrient delivery, and regulates
and metabolizes energy substrates. Astrocytes transport
glucose via GLUT1 transporters (reviewed in Maher et al.,
1994). Compared to neurons, astrocytes express high levels
of 6-phosphofructose-2-kinase/fructose-2,6-bisphosphatase-3
(PFKFB3), producing fructose-2,6-bisphosphate, activating
in turn phosphofructokinase-1 (PFK) (Almeida et al., 2004;
Herrero-Mendez et al., 2009). Astrocytes are, therefore, prone
to aerobic glycolysis (Barros and Deitmer, 2010) and early
studies have supported that glycolysis can be stimulated by
neuronal activity (Kasischke et al., 2004), astrocytic glutamate
uptake (Pellerin and Magistretti, 1994; Takahashi et al., 1995;
Tsacopoulos et al., 1997) and extracellular K+ (Peng et al.,
1994). Recently, using the genetically encoded fluorescence
resonance energy transfer (FRET) lactate sensor Laconic, a
lactate gradient from astrocytes to neurons was demonstrated in
vivo (Mächler et al., 2016). The two ATPs glycolytically-produced
have been proposed to serve the energetic demands associated
with glutamatergic activity in fueling both the Na+/K+-
ATPase pump coupled to glutamate transport (consuming
one ATP) and the glutamine synthetase (consuming another
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ATP) for the maintenance of the glutamate-glutamine cycle
(Pellerin and Magistretti, 1994). On the other hand, neurons
constantly degrade PFKFB3 (Almeida et al., 2004; and reviewed
in Bolaños et al., 2010) and neuronal activation of PFKFB3
was shown to lead to oxidative stress and neuronal apoptosis
(Herrero-Mendez et al., 2009). Astrocytic-produced lactate was
therefore proposed to alternatively fuel neurons for oxidative
metabolism during neuronal activity, in line with stimulation
of glycolysis by K+ (Peng et al., 1994; Bittner et al., 2011),
by glutamate (Pellerin and Magistretti, 1994), and increased
lactate eﬄux by K+ (Sotelo-Hitschfeld et al., 2015) and NH+4
(Provent et al., 2007; Lerchundi et al., 2015), while neuronal
glucose to be diverted into the pentose phosphate pathway for
antioxidant defense during enhanced work at the respiratory
chain (Bouzier-Sore and Bolaños, 2015). The study by Sibson
et al. in the rat brain suggesting 1:1 stoichiometry between
neuronal glucose oxidation and the glutamate-glutamine cycle
rate (Sibson et al., 1998) provided support to this early view
of compartmentation of brain metabolism. However, this
hypothesis did not consider (or exclude) stimulation of glial
oxidative metabolism to support increased neurotransmission
rates. Yet, hexokinase was shown to be highly expressed in
neurons as compared to astrocytes (Lundgaard et al., 2015),
which is consistent with the ability of neurons to rapidly
upregulate their glycolytic activity to fuel energy demand. In
line with this, it was reported that increased glycolysis occurs
for example in nerve terminals of bicuculline-treated rats (Patel
et al., 2014), and in cultured neurons exposed to high K+ (Peng
and Hertz, 2002).
Stimulation of Glial Oxidative Metabolism
In vitro
Although glycolytic activity is higher in glia than in neurons,
astrocytes express an important number of enzymes involved
in the TCA cycle, suggesting substantial oxidative capacity. In
particular, about 45 and 16% of gene expression in astrocytes is
dedicated to energy homeostasis and energy substrate transport,
respectively, and TCA cycle related genes (i.e., citrate synthase,
aconitase, isocitrate dehydrogenase, oxoglutarate dehydrogenase,
dihydrolipoamide s-succinyltransferase, succinyl-CoA ligase,
succinate dehydrogenase, fumarase, malate dehydrogenase) have
larger expression in astrocytes than in neurons (Lovatt et al.,
2007). Moreover, an important amount of small mitochondria
was detected in the fine astrocytic processes (Derouiche et al.,
2015) and shown to co-localize with EAAT (Genda et al.,
2011; Jackson et al., 2014), which might facilitate coupling of
astrocytic respiration with glutamate uptake (Eriksson et al.,
1995). Additionally, elevation in astrocytic Ca2+ coincide
with mitochondria position within the processes (Jackson and
Robinson, 2015), and a rise in mitochondrial Ca2+ concentration
might stimulate TCA cycle activity and thus ATP production
(Wan et al., 1989; Denton, 2009). Consistent with glial metabolic
activation by neuronal activity (Eriksson et al., 1995) and
stimulation of Na+/K+-ATPase by extracellular K+ (Hajek et al.,
1996; Honegger and Pardo, 1999), the fraction of glutamate that
is metabolized through glial TCA cycle was reported to increase
with extracellular glutamate application to astrocytes (McKenna
et al., 1996).
Glial Oxidative Metabolism In vivo
A few in vivo studies have investigated themetabolic involvement
of glia during neuronal activation. In particular, autoradiography
studies using the glial-specific energy substrate acetate
demonstrated increased glial oxidative metabolism during
both acoustic (Cruz et al., 2005) and photic (Dienel et al.,
2007b) stimulations in awake rats. Similarly, positron emission
tomography (PET) along with [1-11C]acetate infusion showed
increased astrocytic oxidative metabolism during infraorbital
nerve stimulation of anesthetized rats and visual stimulation
in humans (Wyss et al., 2009). Using dual photon fluorescence
confocal microscopy, Lind et al. showed that during trigeminal
nerve stimulation of anesthetized mice about 70% of astrocytes
respond to stimulation with Ca2+ increase (Lind et al., 2013).
With the same methodology the glial activation map was
reported to resemble that of neurons during rat paw stimulation,
suggesting both neuronal, and glial topographical representation
of the body in the cortex (Ghosh et al., 2013), and pointing to
significant glial activation during neuronal activity.
While these techniques present high spatial resolution,
they are associated with some disadvantages, such as the
need of radioactive tracers and ionizing radiations (PET,
autoradiography), invasiveness (dual photon fluorescence
confocal microscopy, FRET, autoradiography), potential cellular
toxicity (FRET), the lack of absolute quantification in the case
of FRET (as signal magnitude directly rely on the number of
molecules of interest binding the sensor), and the lack of chemical
specificity (PET, autoradiography) for providing quantitative
information on metabolic pathways underlying oxidative
metabolism. Currently, the development of tracers detectable
by MRS, such as 13C-labeled substrates, the improvement of
detection modalities (Henry et al., 2003), the progress in building
adequate mathematical models (Gruetter et al., 2001) along
with the increase in magnetic field strength render possible
detailed compartmentalized metabolic flux characterization in
vivo in a non-invasive manner and with minimal assumptions
(Duarte et al., 2011; Duarte and Gruetter, 2013; Dehghani et al.,
2016; Sonnay et al., 2016, 2017). In particular direct detection
of 13C-labeled compounds (13C MRS) provides quantitative
assessment of major metabolic pathways including glycolysis,
TCA cycle, glutamate-glutamine cycle and pyruvate carboxylase
(Gruetter et al., 2001; Henry et al., 2006; Duarte et al., 2011).
Direct detection of 13C-labeled compounds is a technique that
has been robustly implemented and can be applied to small
animal metabolism studies in the whole brain (Duarte et al.,
2011) or in specific cerebral regions (Patel et al., 2005a; Sonnay
et al., 2016, 2017).
DYNAMIC 13C MAGNETIC RESONANCE
SPECTROSCOPY (13C MRS)
Nuclear magnetic resonance (NMR) is a non-ionizing and non-
invasive technique based on the magnetic properties of spin-
containing nuclei. This methodology can be used in both clinical
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settings (e.g., Prichard et al., 1991; Rothman et al., 1992; Gruetter
et al., 1994, 1998a, 2001; Shen et al., 1999; Gruetter, 2002; Lebon
et al., 2002; de Graaf et al., 2004; Mangia et al., 2007; Oz et al.,
2007, 2015; Lin et al., 2012; Schaller et al., 2013, 2014; Bednarˇík
et al., 2015) and pre-clinical studies (e.g., Mason et al., 1992;
Hyder et al., 1996, 1997; Sibson et al., 1998, 2001; Choi et al.,
2002; Henry et al., 2002; Patel et al., 2004, 2005a; Deelchand
et al., 2009; Duarte and Gruetter, 2013; Duarte et al., 2011, 2015;
Mishkovsky et al., 2012; Just et al., 2013; Bastiaansen et al., 2013,
2015; Lanz et al., 2014; Sonnay et al., 2015, 2016, 2017). However,
in most animal applications it requires anesthesia, which can
modify the coupling between neuronal activity, brainmetabolism
and vascular regulation of blood flow (Masamoto and Kanno,
2012; Sonnay et al., 2017, and references therein).
Several nuclei can be used to investigate brain metabolism,
notably 1H, 31P, or 13C. In the case of phosphorus, 31P
MRS is used to investigate energy metabolism by providing
information on the energy status of endogenous phosphate
compounds, namely ATP, ADP, and PCr (e.g., Zhu et al., 2009).
1HMRS is based on local environment-dependent 1H present in
metabolites (discarding water that is several orders of magnitude
more concentrated) and assesses changes in total metabolite
concentrations (generally in the mM range) involved in
energy metabolism, osmoregulation, membrane metabolism and
myelination (reviewed in Duarte et al., 2012). The main challenge
associated with 1H MRS is the complexity of the neurochemical
profile composed of several overlapping metabolite signals on
a relatively small frequency range (i.e., 4–5 ppm) that is to be
analyzed (de Graaf, 1998). An extension of this technique is
1H functional MRS (fMRS) that focuses on time-dependent
changes in metabolite concentrations, which are associated with
metabolic pathways during brain activity (Prichard et al., 1991;
Mangia et al., 2007; Lin et al., 2012; Just et al., 2013; Schaller et al.,
2013, 2014; Bednarˇík et al., 2015). The difficulty associated with
the detection of small concentration changes occuring during
neuronal activation can yet be overcome by using high magnetic
field MR system (≥9.4 T) to increase spectral resolution and
sensitivity.
Direct 13C MRS can measure 13C isotope incorporation (or
fractional enrichment, FE) over time into different molecules
and into specific positions within the same molecule (i.e., 13C
isotopomers), with signals distributed over a large chemical shift
range, namely about 200 ppm. Since the 13C isotope has a natural
low abundance (1.1%), a low background signal is detected.
However, as 13C gyromagnetic ratio is ¼ of that of 1H, 13C
MRS is an insensitive technique as compared with 1H MRS.
This is the reason why 13C tracers are infused in a substantial
amount to enable proper signal detection. The 13CMRS detection
threshold in vivo is typically in the mM range and it is usually
not possible to measure TCA cycle intermediates that are present
in smaller quantities. However, amino acids (e.g., glutamate,
glutamine, and aspartate), which are in exchange with TCA
cycle intermediates, are present at higher concentrations and can,
therefore, bemeasured and used formetabolic modeling and thus
for estimation of fluxes across major biochemical pathways.
On the other hand, dynamic nuclear polarization (DNP) can
be used to increase 13C polarization of 13C-labeled substrates,
and thus offers potentially tremendous signal enhancement and
detection of 13C labeling in tissue’s TCA cycle intermediates, such
as 2-oxoglutarate in the brain (Mishkovsky et al., 2012), or citrate
in the heart (Schroeder et al., 2009; Bastiaansen et al., 2015).
While such a technique can probe metabolism in vivo with high
sensitivity and a time resolution of 1 s, the acquisition window
is limited to approximately a minute (Comment, 2016), since
MR acquisition needs to be performed within the time decay
(seconds) of the enhanced nuclear polarization, and detection of
downstream compounds depends notably on the turnover rates
and on the concentration of labeled metabolites produced within
the recording period (discussed in Mishkovsky et al., 2012).
Moreover, further developments are required to actually translate
the detection and measurement of hyperpolarized 13C in vivo to
quantification of metabolic fluxes (Bastiaansen et al., 2013).
The strong heteronuclear scalar coupling between 13C and 1H
nuclei complicates the spectra (i.e., splitting of 13C resonances in
multiplets with reduced peak height) and reduces the sensitivity,
so that additional hardware is required for 1H decoupling during
acquisition (discussed in Henry et al., 2006). Homonuclear 13C
couplings are also observable and the presence of 13C multiplets
depends on the simultaneous presence of 13C spins in the
same molecule at adjacent positions. Although assessment of
13C multiplets with high temporal resolution is challenging
because of low signal amplitude, their inclusion in mathematical
modeling (i.e., bonded cumomer approach) improves reliability
and independency of the estimated brain metabolic fluxes
(Shestov et al., 2012; Tiret et al., 2015; Dehghani et al., 2016).
The evaluation of 13C enrichment curves over time of carbon
containing molecules requires the use of multi-compartment
models describing best the data (de Graaf et al., 2003, 2004;
Patel et al., 2004, 2005a, 2010; Henry et al., 2006; Lanz
et al., 2013). As a simplified view of the real biochemical
network, a model is a set of metabolite pools interconnected
by the major biochemical reactions that are associated with
metabolic fluxes. Each pool is associated with certain labeling
positions in the atomic chain of one metabolite synthesized
downstream from the infused compound: therefore there are
at least as many labeling equations as carbon positions. The
model contains the measurable entities and the non-measurable
pools that are present in lower concentrations (e.g., TCA cycle
intermediates) and that reach steady-state labeling much faster
than larger pools, such as amino acids (Uffmann and Gruetter,
2007). The model can combine isoenzymes, parallel pathways
that result in the same labeled pools, intermediate pools that
equilibrate rapidly (e.g., pyruvate/lactate) or which enzymes are
assumed not to be involved in other processes (e.g., glycolysis).
According to the complexity to reach, the model can assess
reversibility of reactions, sub-compartmentation or transport
across membranes (reviewed in Henry et al., 2006). Based on
the known biochemical reactions, a model should, therefore, be
as simple as possible and as complex as necessary to describe
measured parameters, focusing on the relevant pathways leading
to metabolic observations and neglecting the influence of others
(e.g., presence of cofactors, much slower reactions).
Derivation of metabolic fluxes is usually performed using
dynamic positional enrichment (total amount of label
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accumulated at individual position without distinguishing
within multiplets; de Graaf et al., 2004; Duarte et al., 2011;
Sonnay et al., 2016, 2017). The metabolic model describing
13C labeling is solved mathematically by a set of coupled linear
differential mass-balance equations describing the system at
equilibrium (i.e., metabolic but not isotopic steady-state). It
assumes mass and energy conservation (i.e., constant fluxes and
pool size over time), instant and uniformly labeling of the pools,
and equal probability for a labeled or non-labeled molecule to
enter and leave a pool (Mason et al., 1992 and see Lanz et al., 2013
for mathematical details). This latter assumption is plausible
given that the biochemical reactions are fast compared to the
temporal resolution of the MR acquisition techniques. Note that
the metabolic steady-state assumption might not necessary hold
under certain conditions (Lanz et al., 2014).
Isotopomers from [1,6-13C2] Glucose
An extensively used substrate for two-compartment (i.e.,
neurons vs. astrocytes) brain metabolism investigation is [1,6-
13C2]glucose (Lanz et al., 2013). On a general principle,
[1,6-13C2]glucose crosses the BBB through facilitate glucose
transporters (GLUT), is taken up by neurons and astrocytes, and
1 mole of glucose is metabolized through glycolysis (cytosolic
reaction) to produce 2 moles of [3-13C]pyruvate (1 mole of [1-
13C]glucose only produces 1 mole of [3-13C]pyruvate, resulting
in two-fold reduced 13C labeling of pyruvate). Two moles
of [2-13C]acetyl-CoA is then synthetized by PDH. Then in
the first turn of the mitochondrial TCA cycle, [2-13C]acetyl-
CoA will label position C4 of 2-oxoglutarate. Due to the
transmitochondrial exchange mediated notably by GDH and
AST, cytosolic glutamate C4 is in turn labeled (the carbon
positions are maintained). Due to the symmetry of the succinate
and fumarate molecules, half of the labeling in position C4 of
2-oxoglutarate is transferred with equal probability to positions
C2 and C3 of oxaloacetate, leading to the formation of
[2-13C]aspartate and [3-13C]aspartate from oxaloacetate by AST.
In the second turn of the TCA cycle, labeled molecules of
oxaloacetate combine again with (labeled or unlabeled)molecules
of acetyl-CoA, resulting in the formation of [2-13C]glutamate
and [3-13C]glutamate. Then in the third turn of the TCA
cycle, half of the carbons of position C3 of 2-oxoglutarate
are transferred to position C2, while the other half stays at
position C3. Meanwhile carbons at position C2 are transferred
to position C1 of 2-oxoglutarate or lost as CO2. The aspartate
pool is enriched at position C1, C2, C3 and C4. In astrocytes,
[3-13C]oxaloacetate can be formed from [3-13C]pyruvate by
PC, leading to the formation of [2-13C]2-oxoglutarate and [2-
13C]glutamate. Therefore, [1,6-13C2]glucose, as [1-
13C]glucose,
allows differentiating astrocytes and neurons in labeling positions
C2 and diluting positions C3 (with 12C) of glutamate via the
glial specific enzyme PC, but enhances signal detection at a given
resonance by two-fold compared to [1-13C]glucose (two times
more [3-13C]pyruvate at the end of glycolysis). In the glutamate-
glutamine cycle, the carbon positions are maintained. As the
labeling persists in the TCA cycle, multiple carbon positions
become labeled (Figure 2).
Other labeled substrates can be used to study brain
metabolism by direct 13CMRS in vivo depending on the labeling
pattern. For instance, [2-13C]glucose in the human brain allowed
labeling the carboxyl groups of glutamate and glutamine (i.e.,
positions C1 and C5), and aspartate (i.e., positions C1 and C4;
Li et al., 2016). However, half of labeling is rapidly lost as CO2.
Using uniformly labeled glucose ([U-13C]glucose) increases the
splitting of the resonance C4 of glutamate and glutamine due to
J-coupling with position C5 (Henry et al., 2003). [3-13C]lactate
can be used as an alternative to [1,6-13C2]glucose, but results
in a reduced amount of labeling molecules because of a lower
lactate entry into the brain as compared to [1,6-13C2]glucose
(Duarte et al., 2015). [2-13C]acetate has the particularity of
being metabolized almost exclusively in glia. It produces [2-
13C]acetyl-CoA and the large neuronal glutamate pool becomes
labeled via glial [4-13C]glutamine. Therefore, [2-13C]acetate
allows increasing the sensitivity of the measurements of glial
oxidative metabolism and the glutamate-glutamine cycle in
minimizing the bias toward the large neuronal glutamate pool
(Patel et al., 2010; Lanz et al., 2014). To obtain more precise
measurements on neuronal and glial oxidative metabolism, [1,6-
13C2]glucose can be co-infused with [1,2-
13C2]acetate. However,
advanced modeling approaches are needed to account for
the additional homonuclear coupling brought by this double
infusion (Deelchand et al., 2009).
Compartmental Models of Brain
Metabolism
One-Compartment Model
The one-compartment model (Figure 3A) was the first metabolic
model used to describe the turnover curves following infusion
FIGURE 2 | Schematic overview of labeling transfer during
[1,6-13C2]glucose or [1-
13C]glucose infusion. The splitting of the labeling
after OG is due to the symmetry at the succinate and fumarate level. The
indexes represent the carbon positions that become labeled. The first, second,
and third turns of the TCA cycle are represented by solid, dashed, and dotted
lines, respectively. The glial specific reaction driven by pyruvate carboxylase
(VPC ) labels position C2 and dilutes position C3. Glc, glucose; Lac, lactate;
Pyr, pyruvate; Asp, aspartate; OAA, oxaloacetate; OG, 2-oxoglutarate; Glu,
glutamate; Gln, glutamine; VTCA, TCA cycle rate; VX, transmitochondrial
exchange rate (modified from Lanz et al., 2013).
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FIGURE 3 | Schematic view of the (A) one- and (B) two-compartments model. (A) As glutamate is mainly located in neurons, the one-compartment model
represents neurons. This model is characterized by the total TCA cycle rate (VTCA ), the transmitochondrial exchange rate (VX ) and to some extent the
neurotransmission rate modeled by the glutamine exchange rate (VGln). A dilution factors (Vdil ) regulates the amount of lactate entering and leaving the cell. (B) The
two compartments are linked by the glutamate-glutamine cycle. Plasma glucose is transported into the cells down its concentration gradient via GLUT1 (in glial) and
GLUT3 (in neurons) transporters. Once inside glucose is processed through glycolysis into pyruvate. Pyruvate enters then the TCA cycle to produced energy and
amino acids. The glial-specific enzyme, pyruvate carboxylase (PC), produces de novo molecules of glutamate by carboxylation of pyruvate into oxaloacetate. Glc,
glucose; Lac, lactate; Pyr, pyruvate; Asp, aspartate; OAA, oxaloacetate; OG, 2-oxoglutarate; Glu, glutamate; Gln, glutamine; CMRglc, cerebral metabolic rate of
glucose consumption; VPDH, neuronal TCA cycle rate; Vg, glial full oxidation of pyruvate; VPC, pyruvate carboxylase; VGS, glutamine synthetase; VNT,
neurotransmission rate; VX, transmitochondrial exchange rate; Vex, exchange rate with glial glutamine; Vefflux, loss of glial glutamine (or ammonia detoxification =
VPC); Vdil, in (A) dilution at the level of lactate and in (B) dilution rate from glial-specific substrates. Boldface indicates MR-measurable metabolites. The superscripts n
and g indicate neuron and glial, respectively. ATP-dependent reactions are indicated with the red arrows.
of [1-13C]glucose along with 1H-[13C] MRS (i.e., detection of
1H attached to 13C; Mason et al., 1992; Rothman et al., 1992;
Hyder et al., 1996). As most of the glutamate is located in
neurons (Ottersen et al., 1992), this model is assumed to mainly
represent neuronal TCA cycle activity. It allows assessing the
TCA cycle rate (VTCA), the trans-mitochondrial flux (VX) and
a dilution flux at the level of lactate (Vdil, accounting for the
utilization of unlabeled substrates;Mason et al., 1992) from fitting
glutamate and glutamine C4, and Glx (glutamate+glutamine)
C3. Although the astrocytic compartment is not represented
in this model, the neurotransmission rate can be modeled
with a glutamine exchange rate (VGln; Henry et al., 2002).
While 1H-[13C] MRS studies provided an initial measure of
local oxidative metabolism, they were limited to the number
of detected 13C isotopomers and were dependent on several
assumptions regarding glial fluxes (Patel et al., 2004; de
Graaf et al., 2004). With the rapid improvement of MRS
methodology and sensitivity (Gruetter et al., 1994, 1998a;
Henry et al., 2003, 2006), detection of carbon position C2,
C3, and C4 (and their splitting) of glutamate and glutamine
became possible (i.e., direct detection of 13C-labeled compounds)
resulting to the development of two-compartments models with
minimum assumptions regarding glial fluxes (Gruetter et al.,
2001).
Two-Compartment Models
Two-compartment models describe compartmentalization of
brain energy metabolism between glutamatergic neurons and
astrocytes linked by the glutamate-glutamine cycle (Figure 3B).
In contrast to the one-compartment model, this model can
estimate up to nine independent fluxes from the labeling
curves of glutamate, glutamine, and aspartate (Duarte et al.,
2011; Sonnay et al., 2016, 2017) resulting in up to thirteen
parameters that can be assessed when combining some of
the fitted fluxes. More precisely, the fitted parameters are the
neurotransmission rate (VNT; i.e., glutamate-glutamine cycle
representing neurotransmission), the neuronal and glial TCA
cycle (i.e., VPDH and Vg, representing glial full pyruvate
oxidation), pyruvate carboxylase activity (VPC), the trans-
mitochondrial exchange rates describing the combined effects
of AST, GDH and transport across mitochondrial membrane
occurring in neurons (VnX) and in glia (V
g
X), glial glutamine
exchange (Vex), pyruvate/lactate influx from plasma (Vin) and
dilution from glial specific substrates (i.e., acetate and fatty
acids) (Vdil). In addition, calculated fluxes are total glial TCA
cycle activity (V
g
TCA = Vg + VPC), the glutamine synthetase
rate (VGS = VNT + VPC), the total cerebral metabolic rate of
glucose oxidation (CMRglc(ox) = [V
n
TCA + V
g
TCA + VPC]/2)
and the pyruvate/lactate out-flux from the brain parenchyma
(Vout = 2CMRglc-2CMRglc(ox) + Vin). CMRglc is the cerebral
metabolic rate of glucose and is usually determined together
with the apparent maximum transport (Tmax) and the apparent
Michaelis constant of glucose transport Kt using labeling of
plasma and brain glucose (Duarte et al., 2011; Sonnay et al.,
2016, 2017). In glial cells, GLS is neglected because the net
13C labeling follows the direction of glutamine synthesis. Vex
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can exchange with unlabeled glutamine of undefined origin
(Oz et al., 2004) or the proposed 1H MR invisible but 13C
labeled glutamine pool (Duarte and Gruetter, 2013). Besides
the contribution to amino acid synthesis, VPC also represents
glutamine eﬄux (Veﬄux) from the brain (i.e., ammonia disposal)
and maintains the mass balance in the glial TCA cycle (Lee et al.,
1998). Glutamate oxidation in the model is possible through VX
(composite representation of AST and GDH). Note that both
VGln and VNT represent the glutamate-glutamine cycle. One is
rather used in the one-compartmentmodel (VGln) as an exchange
rate between glutamate and glutamine, while the other in the
two-compartment model (VNT).
Flux Information Brought by the Turnover Curves of
Amino Acids
Labeling of a particular nucleus depends on pool size and the
numbers of upstream and downstream fluxes (Henry et al., 2006),
affecting therefore the shapes of the turnover curves differently.
Glutamate is the most concentrated amino acid observed by 13C
MRS (Figure 4). Glutamate labeling depends on both VTCA and
VX, meaning that these two fluxes play an important role in
defining glutamate turnover. While glutamate C4 relies on the
composite flux Vgt, that is VX.VTCA/(VX + VTCA), glutamate
C3 and C2 depend on independent contribution of Vgt, VX, and
VTCA (reviewed in Lanz et al., 2013), because they are labeled in
the second turn of the TCA cycle. Therefore, the information
concerning VX is mainly stored in the initial slopes of the
turnover curves of position C4, C3, and C2 of glutamate (for
VnX) and glutamine (for V
g
X). In the special case of V
g
X, this flux is
particularly difficult to estimate, because labeled molecules from
the glial TCA cycle into glial glutamate can also be transferred
via VPC (Figure 2). The value of VX has been matter of debate for
a long time, as it has been considered by some to be much larger
than VTCA (Mason et al., 1992; Patel et al., 2004; Yang et al., 2009),
but it was also estimated to be on the same order of magnitude of
VTCA, as reflected in a delay in the C3 and C2 labeling relative
to C4 (Gruetter et al., 2001; Oz et al., 2004; Duarte et al., 2011;
Duarte and Gruetter, 2013; Lanz et al., 2014; Sonnay et al., 2016).
The neurotransmission rate, VNT, represents the conversion
of glutamate to glutamine and vice versa. In this process the
carbon positions are maintained. Therefore, VNT mostly depends
on the relative steady-state enrichment of the turnover curves of
glutamate and glutamine: the closer they are to each other, the
faster VNT.
The first turn of the TCA cycle results in label transfer from
glucose to glutamate (via VX). Usually glutamate C4 is the
first detectable peak in a spectrum during an experiment, as it
appears within the first 5 min of infusion (Patel et al., 2005a;
Duarte et al., 2011; Sonnay et al., 2016 and reviewed in de
Graaf et al., 2003). Then, in the subsequent TCA cycle label is
transferred from position C4 to C3 and C2. In neurons, VPDH
will therefore rely on the slope and the steady-state enrichment of
the turnover curves of position C4, C3, and C2 of glutamate and
glutamine, as labeling from glutamate is transferred to glutamine.
As aspartate is mainly labeled via transamination of the TCA
cycle intermediate oxaloacetate, the slope and the steady-state
enrichment of position C3 andC2 of aspartate are further affected
by VPDH. The slopes of the labeling curves reflect, the rate of
VPDH. In glia the situation is different, since label dilution due to
VPC can occur. VPC dilutes position C3 and labels position C2 of
glutamate and glutamine. Therefore, fast Vg results in a relatively
high and steep glutamine C3 turnover curve (Vg has to be fast to
counterbalance the loss due to VPC).
Diluting position C3 and labeling position C2 of glutamate
and glutamine, the measurement of VPC relies on the relative
curves of position C3 and C2 of glutamate and glutamine, and
the assumption that glutamate is mainly neuronal and glutamine
mainly glial. High C3 and low C2 labeling is associated with slow
VPC, while high C2 and low C3 labeling reflect rather increased
VPC. Therefore, when the FE of glutamine C2 approaches that
of C4, either PC activity is high compared to PDH, and/or
glial-specific dilution of acetyl-CoA (Vdil) occurs.
As mentioned above, Vdil reflects dilution of the acetyl-
CoA pool with specific unlabeled glial substrates. Notably, Vdil
dilutes glial acetyl-CoA 13C labeling relative to its precursor
pyruvate. As the position C4 of glutamate and glutamine only
receives labeling from acetyl-CoA, dilution at this point would
lead to a lower (steady-state) C4 labeling. Since glutamate and
glutamine are mainly present in neurons and glia, respectively,
Vdil is also responsible for lower FE of position C4, C3, and
C2 of glutamine compared to glutamate. However, the effect
of Vdil on enhancing the labeling difference between glutamate
and glutamine is counteracted by VNT, which represents the
glutamate-glutamine cycle. The faster the rate of VNT, the
more similar will be the labeling of glutamate and glutamine.
Note that Vdil in glial acetyl-CoA can result in glutamine
C2 being similar or larger than glutamine C4, which has
been observed in some studies (discussed in Duarte et al.,
2011).
Vex represents an exchange between two putative glutamine
pools, one of which is not released to neurons and may
account for a continuous slow increase in FE over time (Duarte
and Gruetter, 2013). Vex can be in exchange with a
1H MR
invisible but 13C labeled glutamine pool (Hancu and Port,
2011) or with unlabeled amino acids from the blood (i.e.,
glutamine), as astrocytes envelop capillaries (Oz et al., 2004).
This second glutamine pool could be associated with biosynthetic
pathways, which have rates much slower than mitochondrial
energy metabolism (McKenna, 2007). The effect of Vex is
in practice observable near the end of an experiment, when
the labeling of glutamine still increases, while glutamate is at
steady-state.
The difference Vout-Vin directly reflects whether the labeling
from plasma glucose is enough to fuel the whole downstream
metabolism since Vout-Vin = 2CMRglc-2CMRglc(ox). Therefore,
if mitochondrial metabolism is faster than glycolysis, oxidation
of additional substrates, such as lactate, must occur under
certain conditions (Sonnay et al., 2017). In resting human brain,
however, the brain exports lactate to the blood stream (discussed
in Dienel, 2012).
The above descriptions are purely indicative of what happens
for each flux independently. Experimental data is a linear
combination of many fluxes, which will adjust during fitting
process to best describe the turnover curves.
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FIGURE 4 | Typical 13C MRS spectra acquired in vivo in the rat brain during [1,6-13C2]glucose infusion at 14.1T (reproduced from Duarte et al., 2011).
Panel (A) shows a time course of 13C labeling with a temporal resolution of 5.3 min. The spectrum in (B) was acquired for 1.8 h, starting 3.5 h after the infusion onset.
Panel (C) is an expansion of B depicting multiplets originated from isotopomers of glutamine (Gln), glutamate (Glu) and aspartate (Asp).
INCREASED GLIAL AND NEURONAL
GLUCOSE OXIDATION WITH NEURONAL
ACTIVITY ASSESSED BY 13C MRS
The first 13C MRS data acquired in vivo upon stimulus-induced
brain activity were modeled using a one-compartment model
and reported a marked increase in total TCA cycle activity in
the somatosensory cortex of stimulated rats compared to rest
(Hyder et al., 1996, 1997). The following experiment consisted on
measuring neuronal CMRglc(ox) under three different anesthesia-
induced activity states, namely pentobarbital (deep), α-chloralose
(moderate) and morphine (light) (Sibson et al., 1998). In this
study, energy metabolism was found to be coupled to the rate
of the glutamate-glutamine cycle (representing glutamatergic
neurotransmission, VNT in Figure 3) in a proportion of 1:1
above isoelectricity, and the main assumption of the model was
driven by the astrocyte-neuron lactate shuttle (ANLS) hypothesis
according to which two glycolytic ATP are rapidly produced
to fuel both glutamate uptake via the Na+/K+-ATPase and
glutamine synthetase (Pellerin and Magistretti, 1994). According
to this model, no stimulation of oxidative metabolism should
occur in glia, in contrast to neurons. Later several studies in rat
brain (Patel et al., 2004, 2005a; de Graaf et al., 2004), assuming
VPC as a fixed fraction of VGS (Sibson et al., 2001) and V
g
TCA
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as a fraction of total VTCA (van den Berg and Garfinkelm, 1971;
Lebon et al., 2002), corroborated the stoichiometry. However, it
should be noted that constraining the value of VPC to VGS and
V
g
TCA to the total VTCA implies an effective coupling between glial
oxidative metabolism and neuronal function.
Indeed, the astrocytic processes engulfing synapses are capable
of sensing increased synaptic activity (Iadecola and Nedergaard,
2007; Cheung et al., 2014) and to stimulate metabolism in local
mitochondria (Eriksson et al., 1995; Jackson et al., 2014). The
13C MRS study by Gruetter et al. (2001) in the human brain,
modeling for the first time the occurrence of glucose oxidation
in the glial compartment, indeed demonstrated that a significant
fraction (≈21%) of glucose is also oxidized in astrocytes (Gruetter
et al., 2001). Using a similar model, glial oxidation and pyruvate
carboxylase activity was shown to significantly contribute also
to total glucose oxidation in awake animals (Oz et al., 2004),
and rats anesthetized with α-chloralose (Duarte et al., 2011),
pentobarbital (Choi et al., 2002) and thiopental (Sonnay et al.,
2017). In these rodent studies, going from the awake state to deep
anesthesia, glial metabolism was found to account for 30–40% of
total oxidative metabolism.
Recently, our group further addressed the issue of glial and
neuronal oxidative metabolism coupled to neuronal activity. In
particular, we first measured the cortical changes in metabolic
fluxes induced by electrical stimulation of the four paws of
rats. We observed a similar increase (in absolute terms) of
both glial and neuronal oxidative metabolism resulting from
the increase in glutamate-glutamine cycle rate (Figure 5; Sonnay
et al., 2016). Moreover, about 37% of total glucose oxidation, i.e.,
CMRglc(ox), occurred in astrocytes at rest, 39% during stimulation
and 1CMRglc(ox)/1VNT ≈ 1. Interestingly in this study, as
well as in Patel et al. (2005b), PC did not vary with VNT,
suggesting that de novo synthesis of amino acids is not required
for increases of the glutamate-glutamine cycle, neither there is
increase in glutamine loss from the cortical tissue. Indeed Patel
and Tilghman reported that glutamate can stimulate pyruvate
carboxylation (Patel and Tilghman, 1973). Instead, glutamate
could be oxidized in astrocytes to compensate for the high
cost of glutamate uptake during neurotransmission (McKenna,
2013).
In the study by Sonnay et al. (2016) the resulting incremental
ATP produced by glucose oxidation was in excess of the increase
in ATP required by the glutamate-glutamine cycle per se (i.e., glial
Na+/K+-ATPase extrusion of Na+ that is co-transported with
glutamate and glial glutamine synthetase activity). While the fate
of neuronal ATP is likely involved in supporting other functions
than the glutamate-glutamine cycle, such as stabilization of
membrane potentials and restoration of ion (Na+, K+, and Ca2+)
gradients across the cell membrane (Attwell and Laughlin, 2001),
the role of the considerable amount of ATP produced in glial
cells (as estimated from recent 13C MRS experiments in rodents;
Duarte et al., 2011, 2015; Sonnay et al., 2016, 2017) is still
unclear and likely extends beyond fueling glutamine synthetase,
the Na+/K+-ATPase and the Ca2+-ATPase (Fresu et al., 1999).
K+ uptake has been recently suggested to fully account for
astrocytic energy consumption (DiNuzzo et al., 2017). However,
the simulations by DiNuzzo et al. are still unable to account for
substantial V
g
TCA in cases of low glutamate-glutamine cycle rate.
To summarize, in addition to the proposed coupling
of neuronal oxidative metabolism and neurotransmission,
astrocytes increase their oxidative metabolism too, resulting
in a large production of ATP. It is, therefore, important to
investigate the exact fate of the ATP produced. In this context,
the ATP produced in glia might notably support blood flow
regulation (Zonta et al., 2003; Metea and Newman, 2006),
neuronal activity modulation (Volterra and Meldolesi, 2005) and
protection against oxidative stress (Borst and Elferink, 2002;
Dringen and Hirrlinger, 2003). Glycogenolysis might moreover
provide energy to support neurotransmission (i.e., release and
uptake of glutamate; Sickmann et al., 2009).
FUNCTIONS OF ASTROCYTES IN THE
BRAIN
Blood Flow Regulation
Brain vasculature is rich in arterioles and fine capillaries (Reina-
De La Torre et al., 1998), and CBF regulation is mainly
controlled by relaxation and constriction of these blood vessels
(Attwell et al., 2010). In this context astrocytes and neurons are
FIGURE 5 | Relation of estimated total, neuronal and glial glucose oxidative metabolism to the glutamate-glutamine cycle in the rat cortex
anesthetized with α-chloralose (originally reported in Sonnay et al., 2016). Metabolic fluxes are in µmol/g/min. Average fluxes across the resting (in blue) and
stimulated (in red) group are shown with associated SD.
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presumed to play a key role in modulating CBF to match energy
demands. In neurons, upon NMDA activation intracellular
Ca2+ concentration increases, which activate phospholipase
A2 (PLA2) in the cytosol that then produces arachidonic
acid (AA). In astrocytes, activation of mGluR by glutamate
triggers the translocation of the α-subunit of the receptors to
phospholipase C (PLC) mediating the conversion of GTP to
GDP (Bockaert et al., 1993). Activated PLC cleaves membrane
phosphatidylinositol 4,5-bisphosphate (PIP2) to diacylglycerol
(DAG) and inositol 1,4,5-triphosphate (IP3) that triggers Ca
2+
increase. In neurons, cyclooxygenase (COX) converts AA into
prostaglandins E2 (PGE2) leading to vessel dilation (Wang et al.,
2005). In astrocytes, AA can be converted either to PGE2 by
COX (Zonta et al., 2003) or to epoxeicosatrienoic acids (EET)
by epoxygenase, which diffuse through pericytes (Hamilton et al.,
2010; or smooth muscle cells for arteries) for blood vessel
dilation. If AA is converted into 20-hydroxyeicosatetraenoic
acid (20-HETE) by ω-hydroxylase in pericytes, it will cause
vasoconstriction (Metea and Newman, 2006). New line of
evidence suggest moreover that the astrocytic production of
PGE2 might be dependent on glutathione levels (Howarth
et al., 2017, and references therein). In neurons activation of
ionotropic glutamate receptors located on the post-synaptic
zone (i.e., NMDA) also activates nitric oxide synthase (NOS),
which in turn produces NO. Interaction of NO with soluble
guanylate cyclase (sGC) triggers cGMP dependent vasodilation
mechanisms (Laranjinha et al., 2012; Lourenço et al., 2014).
Moreover, neuronal vesicular ATP can be released and act on
astrocytic purinergic receptors (P2Y) to raise intracellular Ca2+
concentrations mediating the conversion of GTP to GDP and
PLC activation (reviewed in Erb and Weisman, 2012; Bazargani
and Attwell, 2016). Alternatively, ATP can also intracellularly
be converted to adenosine by adenylate kinase cytosolic 5′-
nucleotidase (reviewed in Iadecola, 2004). Intracellular adenosine
FIGURE 6 | Schematic representation of possible signaling pathways mediating neurovascular coupling. Activation of glutamate receptors (mGluR, NMDA)
triggers increases in Ca2+ concentration. Ca2+ increase upon mGluR activation is mediated by phospholipase C (PLC) and inositol 1,4,5-triphosphate (IP3).
Arachidonic acid (AA) is then produced by phospholipase A2 (PLA2). In astrocytes AA can be converted either to prostaglandins E2 (PGE2 ) by cyclooxygenase (COX)
or to epoxeicosatrienoic acids (EET) by epoxygenase for vasodilation. If AA is converted into 20-hydroxyeicosatetraenoic acid (20-HETE) by ω-hydroxylase, it will lead
to vasoconstriction. In neurons, increase in Ca2+ concentration results in either PGE2 or nitric oxide (NO) production via NO synthase (NOS). In pericytes and smooth
muscle cells NO interacts with the soluble guanylate cyclase (sGC) for cGMP- dependent vasodilation mechanisms. Neuronal release of vesicular ATP can activate the
astrocytic purinergic receptors (P2Y) to raise intracellular Ca2+ concentration. Intracellular ATP can be converted to adenosine by adenylate kinase cytosolic
5′-nucleotidase. Intracellular adenosine can be transported by the nucleoside transporters to activate the adenosine receptors (AR) for cAMP-dependent vasodilation
mechanisms via adenylate cyclase and inhibiting the vasoconstrictive effects of 20-HETE. Lactate can inhibit the astrocytic prostaglandin transporter (PGT)-mediated
PGE-lactate exchange, increasing therefore extracellular PGE2 concentration. K
+ and H+ ions, associated notably to action potentials and oxidative metabolism,
respectively, can also modulate vasodilation. Astrocytes can modulate synaptic plasticity in releasing vesicles containing glutamate, D-serine, ATP and neurotrophic
factors in an ATP-dependent manner. Glutathione is produced in astrocytes and can be released through multidrug resistance proteins (MRP) mediating ATP
hydrolysis. Release of ascorbate mediate non-hydrolytic ATP binding to volume-sensitive organic osmolyte-anion channel (VSOAC) and is stimulated by glutamate.
The left and right cells represent an astrocyte and a neuron, respectively. The difference in TCA cycle size reflects the fact that neurons are more oxidative than
astrocytes. The red circle is a blood vessel, the surrounding darker layer represents the endothelial cells and the thicker outer line is the smooth muscle cells (or
pericytes). Word in bold red and bold purple corresponds to energy-producing and consuming processes, respectively. Enzymes are in gray italic. The dashed line
represents vasodilation and the dotted line vasoconstriction.
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can be released extracellularly by nucleoside transporters (Iliff
et al., 2003), which can in turn act on adenosine receptors
located on pericytes (Iliff et al., 2003; Gordon et al., 2008) and
trigger the activation of adenylate cyclase (in mediating the
conversion of GTP to GDP) that converts ATP to cAMP (Suzuki
et al., 1988). Increase in cAMP leads to vasodilation and inhibits
the vasoconstrictive effects of 20-HETE (Koehler et al., 2006;
Figure 6).
Other lines of evidence suggest that the transfer of excess
electrons from NADH to O2 by NADH oxidase (Wolin, 1996)
can generate O−2 , which raises intracellular Ca
2+ levels (Ikebuchi
et al., 1991) activating in turn NOS for NO production (Ido et al.,
2001).
Two different dynamics of Ca2+ signaling have been proposed
to initiate and sustain hemodynamic responses. First, brief
(100ms) Ca2+ responses in astrocytic end-feet, occurring
downstream neuronal activation and scaling with the level
of neuronal activity, triggers vessel dilation onset. Second, a
slower and long lasting (seconds) Ca2+ elevation contributes
to a prolonged blood vessel dilation (Lind et al., 2013). Yet,
the observation that astrocytic Ca2+ can lag a few seconds
arteriolar dilation supports the hypothesis that astrocytic Ca2+-
dependent mechanisms may not be a prerequisite for CBF
response initiation (Nizar et al., 2013). Local CBF response
could be immediately regulated by fast (400 ms) feed-forward
mechanisms directly related to neuronal activity (e.g., neuronal
NO production (Buerk et al., 2003), action potential-associated
K+ current (Paulson and Newman, 1987), neuronal arachidonic
pathway activation Zonta et al., 2003; Metea and Newman, 2006),
rather than feedback mechanisms associated with metabolism
(e.g., lactate, astrocytic mGluR-related signaling, ATP-derived
adenosine signaling), that probably occur at longer time scales
(seconds) to match CBF with energy demands (discussed in
Buxton, 2010). In this context the fact that the CBF/CMRO2 ratio
varies between brain regions, as well with stimulus frequency
(discussed in Buxton, 2010) and length (Lin et al., 2009), further
suggests regulation of this ratio by notably neuronal activity-
associated mechanisms (discussed in Buxton, 2010). Recent data
further address this controversy in suggesting Ca2+-dependent
signaling for modulation of capillary but not arteriolar diameter
(Biesecker et al., 2016). Because CO2, one of the end products
of oxidative metabolism, can diffuse out of the cells and is in
rapid equilibrium with HCO−3 , extracellular H
+ ions can also
locally contribute to CBF regulation (Kuschinsky and Wahl,
1978).
Neuronal Activity Modulation and Synaptic
Plasticity
Although astrocytes do not generate action potentials per se
they can actively modulate synaptic transmission and neuronal
synchronization in mediating notably the release of vesicles-
containing neurotransmitters and neuromodulators, such as
glutamate, ATP, adenosine, and D-serine. Glutamate-containing
microvesicles are present in astrocytes and upon Ca2+ signaling
glutamate molecules are released and can target post-synaptic
receptors (i.e., NMDA, AMPA, mGluR, and kainate) to fine
tune firing threshold (Volterra and Meldolesi, 2005). In the
extracellular space ATP can be converted to adenosine by the
dephosphorylating action of the ectonucleotidase anchored at
the plasma membrane (Joseph et al., 2003). Adenosine can
activate adenosine receptors and therefore modulate neuronal
activity by triggering K+ eﬄux (e.g., Newman, 2003), as well
as intermediary metabolism (Haberg et al., 2000; Hammer
et al., 2001; Duarte et al., 2016) and blood flow (Blood et al.,
2003; Iliff et al., 2003; Gordon et al., 2008). D-serine that
can be released from astrocytes was also shown to modulate
electrical neurotransmission by acting at the glycine binding
site of NMDA receptor (Stevens et al., 2003). Moreover, the
production of neurotrophic factors was shown to promote the
formation and the function of synapses (Pfrieger and Barres,
1997), and to regulate intracellular Ca2+ homeostasis upon
stimulation of the glutamate receptors and thus to preserve
the activity of the mitochondrial electrochemical gradient
and therefore energy metabolism (El Idrissi and Trenkner,
1999). Glutamate, D-serine, ATP and neurotrophic factors
are notably released exocytotically, mediating Ca2+ signaling
and ATP-dependent soluble N-ethylmaleimide-sensitive factor
activating protein receptor (SNARE) disassembly (Goda, 1997;
Parpura and Zorec, 2010), resulting in energy consumption
(Figure 6). The delivery of these vesicles to the plasma
membrane involves cytoskeleton assembly/disassembly (Potokar
et al., 2007) requiring ATP hydrolysis (Korn et al., 1987; Le
Clainche et al., 2003). Interestingly, the number of astrocytic
processes, as well as their contact with active synapses, are
stimulated by extracellular glutamate and also involve actin-
dependent mechanisms (Cornell-Bell et al., 1990) requiring
ATP hydrolysis (Korn et al., 1987; Le Clainche et al.,
2003).
Protection against Oxidative Stress
The use of NADH through the electron transport chain for ATP
production and mitochondrial Ca2+ influx results in reactive
oxygen species (ROS) production (Boveris and Chance, 1973;
and reviewed in Görlach et al., 2015). Yet, the cooperative action
of astrocytes in culture was shown to protect neurons against
ROS toxicity (Desagher et al., 1996), and astrocytes express
larger amounts of antioxidant molecules and ROS-detoxifying
enzymes than neurons (Makar et al., 1994). The thiol group of the
glutathione molecule acts as an important electron donor. While
both neurons and astrocytes synthesize glutathione, neuronal
glutathione levels are higher in the presence of astrocytes
(Dringen et al., 1999), probably because of shuttling of cysteine-
glycine (glutathione precursor) from astrocytes to neurons
(Dringen and Hirrlinger, 2003). Glutathione transport across
cells is notably mediated by multidrug resistance proteins (MRP)
that belong to the subgroup ABCC of the ATP-binding cassette
transporters, which mediate passage via ATP hydrolysis (Borst
and Elferink, 2002; Dringen and Hirrlinger, 2003; Figure 5).
Activation of astrocytic glutamate receptors was shown to
translocate nuclear factor-erythroid 2-realted factor-2 (Nrf2)
(present in lower concentrations in neurons) into the nucleus
and to trigger the expression of antioxidant genes, notably
related to glutathione metabolism (Jimenez-Blasco et al., 2015).
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Astrocytes synthesize large amount of hydrogen sulfide, which
was demonstrated to not only have neuroprotective properties
(Lee et al., 2009), but also act as neuromodulator in enhancing
NMDA responses (Abe and Kimura, 1996) and modulating glial
Ca2+ waves (Nagai et al., 2004).
Ascorbate is also another important antioxidant anion in the
brain and glutamate was demonstrated to stimulate its release
from astrocytes (Wilson et al., 2000), suggesting an essential
protecting role of the ascorbate flux from astrocytes to neurons
during synaptic activity (Acuña et al., 2013). Astrocytes are
responsible for the recycling of the neuronal extracellularly
released dehydroascorbic acid (the oxidized form of ascorbate)
into ascorbate, which can be exported to neurons (Covarrubias-
Pinto et al., 2015). Extracellular transport of ascorbate from
astrocytes is believed to be mediated by volume-sensitive organic
osmolyte-anion channel (VSOAC) that requires non-hydrolytic
ATP binding (Jackson et al., 1994; Covarrubias-Pinto et al., 2015;
Figure 6). Considering the fact that efficacy of the mechanisms
stimulated by astrocytic glutamate uptake depends on the density
of the transporters at the plasma membrane (Robinson, 2002),
efficient trafficking of EAAT2-containing vesicles and exocytosis
must moreover take place (Stenovec et al., 2008).
Glycogenolysis
Glycogen constitutes a glucose storage in the form of highly
branched polysaccharide molecules (Preiss and Walsh, 1981)
found in high concentrations in the liver and in skeletal muscle,
although smaller but significant levels (6–8 µmol/g) are also
estimated in the human brain (Oz et al., 2015). Glycogenesis
(glycogen production from glucose 1-phosphate by glycogen
synthase) and glycogenolysis (glycogen breakdown to glucose 6-
phosphate by the combined action of glycogen phosphorylase
and phosphoglucomutase) mainly occurs in astrocytes (Dringen
et al., 1993; Figure 1), and the latter can be stimulated by
extracellular glutamate and K+ (Hertz et al., 2015). In line with
this, glycogen levels were found to increase with anesthesia
(Morgenthaler et al., 2006) and decrease during somatosensory
(Swanson et al., 1992) and visual (Dienel et al., 2007a)
stimulation. However, no change in brain glycogen level was
measured during visual stimulation in humans (Oz et al., 2007).
While glycogen-derived lactate has been demonstrated to have
a pivotal role in memory formation and consolidation (Gibbs
and Hertz, 2005; Suzuki et al., 2011; Boury-Jamot et al., 2016),
learning mechanism and synaptic strength (Duran et al., 2013),
and neuronal function (Tekkök et al., 2005), the role of glycogen
is unlikely limited to fuel neuronal metabolism. Recently,
astrocytic glycogenolysis was shown to provide energy to sustain
glutamatergic neurotransmission (i.e., glutamate uptake and
release; Sickmann et al., 2009). Glycogen might act as a substrate
for de novo formation of glutamate (Gibbs et al., 2007) and
glycogen-derived energy might be required over glucose-derived
energy for pyruvate carboxylation (Sickmann et al., 2012),
suggesting that astrocytic glycogen metabolism might be crucial
to maintain proper brain function.
CONCLUSION
While the essential role of astrocytes to cerebral function is
now widely accepted, quantitative assessment of their actual
contribution to energy metabolism has been missing, notably
because the methodologies did not allow differentiating between
neurons and astrocytes. Direct 13C MRS along with advanced
metabolic modeling can provide measurements of both neuronal
and glial metabolism in specific brain regions and under various
activation states. In this context, new data indicate that the rate of
astrocytic metabolism is about half of that in neurons, and can be
activated by sensory stimulation and that the astrocytic response
amplitude can be, in absolute terms, as large as in neurons,
suggesting that the changes in ATP requirements associated
with the glutamate-glutamine cycle are coupled with the ATP
produced by glucose oxidation in both compartments.
Increase in neuronal metabolism likely supports
neurotransmission-associated functions, such as restoration
of ion gradients caused by action potentials, post-synaptic
currents, and transport of glutamate into vesicles. Adaptation
of glial metabolism also provides energy for neurotransmission
besides housekeeping tasks, likely fueling the production and
action of modulators of neuronal activity and of synaptic
plasticity, supply of antioxidant molecules and neurotrophic
factors that are necessary for adequate brain function, and
regulation of blood flow and volume. Astrocytes are moreover
important source of glycogen that can be used specifically for
neurotransmission support.
Progress in MR detection methods of 1H and non-1H
nuclei is a promising direction for more detailed and complete
metabolic dataset acquisition. While this provides insights into
cellular function in vivo, it also requires improvement of
current metabolic models describing best energy metabolism.
Simultaneous acquisition of other types of data, such as electrical
activity and blood flow, might contribute to more precise
characterization of the coupling between brain function and
energy metabolism by MRS.
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